Oseltamivir (TAMIFLU): benefit of the neuraminidase inhibitor remains unclear

Dexamfetamine (ATTENTIN) for attention deficit hyperactivity disorder?

Azilsartan (EDABRI) - angiotensin II receptor blocker no. 8

Perioperative management of patients with coronary heart disease taking acetylsalicylic acid

Does anticoagulation for atrial fibrillation protect against myocardial infarction?

Do sulfonylureas increase mortality?

What´s new on SINUPRET?

Placebo refused - how independent research is thwarted

Cancer due to liraglutide (VICTOZA)?

Update: progressive leukoencephalopathy due to natalizumab (TYSABRI)

Consequences of deaths with multiple sclerosis drug fingolimod (GILENYA)